Explore
Premium
Sign Up
Log In
CRT 2017 : Late Breaking Trials: Session III
Conference
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Overview
Late Breaking Trials: Session III
Featuring
Nicolas Shammas
Ron Waksman
William Rollefson
Rafael Romaguera
Add this Moment to your Passport
Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE
with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments.
$30.00 per month. Cancel anytime.
Moment Components
Late Breaking Trial I: Lutonix® Paclitaxel-coated Balloon To Treat Obstructive Lesions In The Superficial Femoral And Popliteal Arteries: Preliminary Six-month Results From The SAFE-DCB Us Registry - Nicolas Shammas
Late Breaking Trial II: Biofreedom USA: The 12 Months Clinical and 9 Months Angio Results - Ron Waksman
Late Breaking Trial IV: Feasibility And Clinical Importance Of Same Versus Next Day Discharge After Elective Transradial Percutaneous Coronary Intervention, The Rasadda-pci Trial - William Rollefson
Late Breaking Trial III: New Drug-eluting Stents In Patients With Diabetes Mellitus And Multi-Vessel Disease (3d Registry) - Rafael Romaguera
Target Audience
Learning Objectives
Related Moments
Percutaneous Treatment Of Coronary Chronic Total Occlusions Part 1: Rationale And Outcomes
Journal
Article on Percutaneous Treatment Of Coronary Chronic Total Occlusions Part 1: Rationale And Outcomes
CRT 2015 Coronary - The Oral Factor Xa Inhibitor Controversy
Conference
A session on The Oral Factor Xa Inhibitor Controversy - from CRT 2015
Rhythm Management of the Atrial Fibrillation Patient: Practical Implementation of the 2012 ESC Guidelines
Journal
Article on Rhythm Management of the Atrial Fibrillation Patient: Practical Implementation of the 2012 ESC Guidelines
Loading Simple Education